Volume-effect in radiation therapy part one: Volume-effect and tumour;L'effet volume en radiothérapie première partie: Effet volume et tumeur

Cancer/Radiotherapie

Volumn 7, Issue 2, 2003, Pages 79-89

  Huchet, A ^a   Caudry, M ^b   Belkacemi Y ^c   Trouette, R ^b   Vendrely, V ^b   Causse, N ^b   Recaldini L ^b   Dahan, O ^b   Wu, J ^a   Maire, J P ^b  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c CENTRE OSCAR LAMBRET   (France)

Author keywords

Cancer; Mathematical models; Radiation therapy; Volume

Indexed keywords

ANGIOGENESIS; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; GANGLIONEUROMA; GLIOBLASTOMA; HUMAN; MATHEMATICAL MODEL; METASTASIS; MOUTH CARCINOMA; NASOPHARYNX CARCINOMA; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DERMATITIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TUMOR VOLUME;

EID: 0038077577     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(02)00002-1     Document Type: Short Survey

References (141)

1. Aebersold DM, Beer KT, Laissue J, Hug S, Kollar A, Greiner RH, et al. Intratumoral microvessel density predicts local treatment failure of radically irradiated squamous cell cancer of the oropharynx. Int J Radiat Oncol Biol Phys 2000;48:17-25.
2. Algan O, Hank GE, Shaer AH. Localisation of the prostatic apex for radiation treatment planning. Int J Radiat Oncol Biol Phys 1995;33:925-30.
3. Arriagada R, Mouriesse BS, Sarrazin D, Clarck RM, Deboer G. Radiotherapy alone in breast cancer, Analysis of tumor parameters, tumour dose and local control: the experience of the Gustave-Roussy institute and the Princess Margaret hospital. Int J Radiat Oncol Biol Phys 1985;11:1751-7.
4. Austin-Seymour M, Chen GT, Rosenman J, Michalski J, Lindsley K, Goitein M. Tumor and target delineation: current research and future challenges. Int J Radiat Oncol Biol Phys 1995;33:1041-52.
5. Baclesse F. Radiotherapy of carcinoma metastatic to cervical lymph nodes, In Treatment of cancer and allied diseases. The head and neck, vol 3, 2nd edition. New York: Paul B, Hoeber; 1959 pp. 641-649.
6. Barillot I, Horiot JC, Pigneux J, Schraub S, Pourquier H, Daly N, et al. Carcinoma of the intact uterine cervix treated with radiotherapy alone: a French cooperative study: update and multivariate analysis of prognostics factors. Int J Radiat Oncol Biol Phys 1997;38:969-78.
7. Bedwinek J. Breast conserving surgery and irradiation: the importance of demarcating the excision cavity with surgical clips. Int J Radiat Oncol Biol Phys 1993;26:675-9.
8. Bentzen SM, Thames HD. Tumor volume and local control probability: clinical data and radiobiological interpretations. Int J Radiat Oncol Biol Phys 1996;36:247-51.
9. Bernier J, Bataini JP. Regional outcome in oropharyngeal and pharyngolaryngeal cancer treated with high dose per fraction radiotherapy, Analysis of neck disease response in 1646 cases. Radiother Oncol 1989;6:87-103.
10. Brenner DJ. Dose, volume and tumor-Control predictions in radiotherapy. Int J Radiat Oncol Biol Phys 1993;26:171-9.
11. Bristow RG, Benchimol S, Hill RP. The P53 gene as a modifier of intrinsic radiosensivity: implication for radiotherapy. Radiother Oncol 1996;40:197-223.
12. Brizel D, Scully S, Harrelson J, Layfield L, Bean J, Prontz L, et al. Tumor oxygenation predict for likehood of distant metastases in human soft sarcoma. Cancer Res 1996;56:941-3.
13. Bucalossi P, Veronesi U, Zingo L, Cantu C. Enlarged mastectomy for breast cancer, Review of 1,213 cases. Am J Roentgenol Radium Ther Nucl Med 1971;111:119-22.
14. Carrie C, Hoffstetter S, Gomez F, Moncho V, Doz F, Alapetite C, et al. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Paediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 1999;45:435-9.
15. Chadha M, Chabon AB, Friedman P, Vikram B. Predictors of axillary lymph node metastases in patients with T1 breast cancer, A multivariate analysis. Cancer 1994;73:350-3.
16. Chua DTT, Sham JST, Kwong DLW, Tai KS, Wu PM, Lo M, et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys 1997;39:711-9.
17. Collin C, Golbold J, Hadju S, Brennan M. Localized soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol 1987;5:601-2.
18. Colonna P, Jais JP, Desablens B, Harousseau JL, Brière J, Boasson M, et al. Mediastinal tumor size and response to chemotherapy are the only pronostic factor in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiothérapie: ten-year result of the Paris-Ouest-France 81/12 trial. J Clin Oncol 1996;14:1928-35.
19. Dachman AH, Mac Eaneaney PM, Adedipe A, Carlin M, Schumm LP. Tumor size on computed tomography scans is one mesurement enough? Cancer 2001;91:555-60.
20. Dachs GU, Chaplin DJ. Microenvironmental control of gene expression: implications for tumor angiogenesis, progression, and metastasis. Semin Radiat Oncol 1998;8:208-16.
21. Daly DE, Westbrook KC, Jesse RH. Head and neck cancer - Interaction of surgery and irradiation. In: Fletcher GH, editor. Textbook of radiotherapy. Third edition. Philadelphia: Lea & Febiger; 1980. p. 237-49.
22. Daşu A, Denekamp J. Inductible repair and intrinsic radiosensitivity: a complex but predictable relationship? Radiat Res 2000;153:279-88.
23. Denekamp J. Physiological hypoxia and its influence on radiotherapy. In: Steel GG, Horwich A & A, editors. The biological basis of radiotherapy. 2nd edition. New York: Elsevier Science Publisher; 1989. p. 115-34.
24. Denekamp J, Daşu A. Inductible repair and the two forms of tumour hypoxia - time for a paradigm shift. Acta Oncol 1999;38:903-18.
25. 2 of R3230AC tumor in Fischer-344 rats. Int J Radiat Oncol Biol Phys 1998;42:723-6.
26. Dosoretz DE, Galmarini D, Rubenstein JH, Katin MJ, Blitzer PH, Salenius SA, et al. Local control in medically inoperable lung cancer: an analysis of its importance in outcome and factors determining the probability of tumor eradication. Int J Radiat Oncol Biol Phys 1993;27:507-16.
27. Dubben HH, Thames HD, Beck-Bornholdt HP. Tumor volume: a basic and specific response predictor in radiotherapy. Radiother Oncol 1998;47:167-74.
28. Dubois DF, Prestidge BR, Hotchkiss LA, Prete JJ, Bice WS. Intraobserver and interobserver variability of MR imaging- and CT-derived prostate volumes after transperineal interstitial permanent prostate brachytherapy. Radiology 1998;207:785-9.
29. Dubray B, Giraud P, Beaupré A. Glossaire de la radiothérapie conformationelle. Cancer Radiother 1999;3:360-6.
30. Dubray B, Mosseri V, Brunin F, Jaulerry C, Poncet P, Rodriguez J, et al. Anemia is associated with lower local control-regional control and survival after radiation therapy for head and neck cancer: a prospective study. Therapeutic Radiology 1996;201:553-9.
31. Dubray B, Pavy JJ, Giraud P, Danhier S, Cosset JM. Les tests prédictifs de la réponse à la radiothérapie : bilan et perspectives en 1997. Cancer Radiother 1997;1:473-83.
32. Dunscombe P, Loose S, Leszczynski K. Size and sources of field placement error in routine irradiation for prostate cancer. Radiother Oncol 1993;26:174-6.
33. Durand RE. Effect of intercellular contact on repair of radiation damage. Exp Cell Res 1972;71:75-80.
34. Durand RE. Repair during multifraction exposures: Spheroids versus monolayers. Br J Cancer 1984(suppl 6):203-6.
35. El Gayed AA, Bel A, Vijlbrief R, Bartelink H, Lebesque JV. Time trend of patient set-up deviation during pelvic irradiation using electronic portal imaging. Radiother Oncol 1993;26:162-71.
36. Epperly MW, Santucci MA, Reed JC, Shield D, Halloran A, Greenberger JS. Expression of the human BCL-2 trangene increase the radiation resistance of hematopoietic progenitor cell line. Radiat Oncol Investing 1995;2:212-8.
37. Fagundes H, Perez CA, Grigsby PW, Lockett MA. Distant metastases after irradiation alone in carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1992;24:197-204.
38. Fletcher GH. Clinical dose-response of human malignant epithelial tumours. Br J Radiol 1973;46:1-12.
39. Franchin G, Minatel E, Gobitti C, Talamini G, Sartor G, Caruso G, et al. Radiation treatment of glottic squamous cell carcinoma, stage I and II: analysis of factors affecting prognosis. Int J Radiat Oncol Biol Phys 1998;40:541-8.
40. Fuks Z, Leibel SA, Wallner KE, Begg CB, Fair WR, Anderson LL, et al. The impact of local control on metastatic dissemination in carcinoma of the prostate: long-term in patients treated with 125-iodine implantation. Int J Radiat Oncol Biol Phys 1991;21:537-47.
41. Fyles A, Milosevic M, Pintilie M, Hill RP. Cervix cancer oxygenation following external radiation therapy. Int J Radiat Oncol Biol Phys 1998;42:751-3.
42. Galper S, Recht A, Silver B, Manola J, Gelman R, Schnitt SJ, et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone. Int J Radiat Oncol Biol Phys 1999;45:1157-66.
43. Giraud P, Antoine M, Larrouy A, Milleron B, Callard P, De Rycke Y, et al. Evaluation of microscopic tumor extension in non-small-cell lung cancer for three dimensional conformal radiotherapy planning. Int J Radiat Oncol Biol Phys 2000;48:1015-24.
44. Giraud P, De Rycke Y, Dubray B, Helfre S, Voican D, Guo L, et al. Conformal radiotherapy (CRT) planning for lung cancer: analysis of intrathoracic organ motion during extreme phase of breathing. Int J Radiat Oncol Biol Phys 2001;51:1081-92.
45. Giraud P, De Rycke Y, Minet P, Danhier S, Dubray B, Helfre S, et al. Estimation de la probabilité d'envahissement tumoral médiastinal : une définition statistique du volume-cible anatomoclinique pour la radiothérapie conformationnelle des cancers bronchiques non à petites cellules ? Cancer Radiother 2001;6:725-36.
46. Goitein M, Schultheiss TE. Strategy for treating possible tumor extension some theoretical consideration. Int J Radiat Oncol Biol Phys 1985;11:1519-28.
47. Goldie JH, Coldman AJ. A mathematical model for relating the drug sensivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 1979;63:1727-31.
48. Graebert T, Osmanian C, Jacks T, Housman D, Kock C, Lowe S, et al. Hypoxia mediated selection of cells with diminished apoptotic potential in solids tumors. Nature 1996;379:88-9.
49. Graf W, Dahlberg M, Osman MM, Holmberg L, Pahlman L, Glibelius B. Short-term preoperative radiotherapy result in down-staging of rectal cancer: a study of 1316 patients. Radiother Oncol 1997;43:133-7.
50. Gray LH, Conger AD, Ebert M, Hornsey S, Scott OCA. Br J Radiol 1953;23:1519-28.
51. Greer PB, Jose CC, Matthews JHL. Set-up variation of patient treated with radiotherapy to the prostate measured with an electronic portal imaging device. Australasian Radiology 1998;42:207-12.
52. Harword AR, Beale F, Cummings BJ, Keane TJ, Payne DG, Rider WD. Supraglottic laryngeal carcinoma: an analysis of dose-time-volume factors in 410 patients. Int J Radiat Oncol Biol Phys 1983;9:311-9.
53. Heineke H. Ueber die Einwirkung der Röntgenstrahlen auf Tiere. Munch Med Woch 1903;50:2090-3.
54. Helminger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat Med 1997;3:177-82.
55. Hewitt HB, Blake ER. The growth of transplanted murine tumors in pre-irradiated sites. Br J Radiol 1968:808-14.
56. Hewitt HB, Blake ER, Walder AS. A critique for active host defence against cancer, personal studies of 27 murine tumors in pre-irradiated sites. Br J Radiol 1976;33:241-59.
57. Hoerni B, Marée D. Le ganglion lymphatique normal et pathologique. Paris: Maloine; 1973 pp. 248-255.
58. Hopewell JW, Calvo W, Reinhold HS. Radiation effects on blood vessels: rôle in late normal tissue damage. In: Steel GG, Horwich A & A, editors. The biological basis of radiotherapy. 2nd edition. New York: Elsevier Science Publisher; 1989. p. 101-13.
59. Hoppe RT, Goffinet DR, Bagshaw MA. Carcinoma of the nasopharynx: eighteen years'experience with megavoltage radiation therapy. Cancer 1976;37:2605-12.
60. Horsman MR. Measurement of tumor oxygenation. Int J Radiat Oncol Biol Phys 1998;42:701-4.
61. Horsman MR, Overgaard J. The oxygene effect. In: Steel G, editor. Basic clinical radiobiology. London: Edward Arnold publisher; 1993. p. 81-8.
62. Horwich A, Easton D, Nogueira-Costa R, Liew KH, Colman M, Peckham MJ. An analysis of prognostic factors in early stage Hodgkin's disease. Radiother Oncol 1986;7:95-106.
63. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy. ICRU Report 50. Bethesda, MD: ICRU; 1993.
64. International Commission on Radiation Units and Measurements. Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50). ICRU Report 62. Bethesda, MD: ICRU; 1999.
65. Jaffray DA, Yan D, Young JW. Managing geometric uncertainty in conformal intensity-modulated radiation therapy. Semin Radiat Oncol 1999;9:4-19.
66. Jagic VN, Schwartz G, Siebenrock L. Blutbefunde bei Röntgenologen. Berl Klin Wchnscft 1911;48:1220-2.
67. Johnson R, Thames HD, Huang D, Schmidt-Ulrich R. The tumor volume and clonogen number relationship: tumor control prediction based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys 1995;33:281-7.
68. Kaplan HS, Murphy ED. The effect of the local roentgen irradiation on the histological behaviour of a transplantable mousse carcinoma, Increased frequency of pulmonary metastasis. J Natl Cancer Inst 1949;9:407-13.
69. Kantor G, Mazeron JJ, Mornex F, Maingon P. Volume tumoral macroscopique (GTV) et volume cible anatomoclinique (CTV) en radiothérapie. Cancer Radiother 2001;5:471.
70. Kerbel RS, Rak J, Kobayashi H, Man MS, Saint Croix B, Graham CH. Multicellular resistance: a new paradigm to explain aspects of acquired drug resistance of solid tumors. Cold Spring Harb Symp Quant Biol 1994;59:661-72.
71. Killoran JH, Kooy HM, Gladstone DJ, Welte FJ, Beard CJ. A numerical simulation of organ motion and daily set-up uncertainties: implication for radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:213-21.
72. Kortmann RD, Hess CF, Meisner MA, Schmidberger H, Bamberg M. Accuracy of field alignment in abdominal radiation therapy. Int J Radiat Oncol Biol Phys 1996;35:779-83.
73. Koscielny S, Tubiana M. Local recurrence and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 1999;43:11-24.
74. Kroonwijk M, Pasma KL, Quint S, Koper PCM, Visser AJ, Heijmen BJM. In vivo dosimetry for prostatic cancer patients using an electronic portal imaging device (EPID) demonstration of internal organ motion. Radiother Oncol 1998;49:125-32.
75. Lavigne JC, Desaive C. Cancer du sein. Interrelation entre la tumeur primitive, les ganglions axillaires et mammaires internes. Bull Cancer 1977;64:421-8.
76. Lee AWM, Sham JST, Poon YF, Ho JHC. Treatment of stage I nasopharyngeal carcinoma: analysis of the patterns of relapse and the result of withholding elective neck irradiation. Int J Radiat Oncol Biol Phys 1989;17:1183-90.
77. Lee CK, Aeppli DM, Bloomfield CD, Levett SH. Hodgkin's disease: a reassessment of prognostic factors following modification of radiotherapy. Int J Radiat Oncol Biol Phys 1987;13:983-91.
78. LeVay J, O'Sullivan B, Catton C, Bell R, Fornaisier V, Cumming B, et al. Outcome and prognostic factors in soft tissue sarcoma in the adult. Int J Radiat Oncol Biol Phys 1993;27:1091-9.
79. Leibel SA, Scott CB, Mohiuddin M, Marcial VA, Coia LR, Davis LW, et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: result of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991;21:559-66.
80. Magee B, Swindell R, Harris M, Barnerjee SS. Pronostic factors for breast recurrence after conservative breast surgery and radiothérapie: result from a randomized trial. Radiother Oncol 1996;39:223-7.
81. Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 2000;74:181-273.
82. Marks LB. A standard dose of radiation for "microscopic disease" is not appropriate. Cancer 1990;66:2498-502.
83. Matsuura K, Hirokawa Y, Fujita M, Akagi Y, Ito K. Treatment result of stage I and II oral tongue cancer with interstitial brachytherapy: maximum tumor thickness is prognostic of nodal metastasis. Int J Radiat Oncol Biol Phys 1998;40:535-9.
84. Mauch P, Tarbell N, Weinstein H, Silver B, Goffman T, Osteen R, et al. Stage I and IIA supradiaphragmatic Hodgkin's disease: prognostic factors in surgically staged patients treated with mantle and paraaortic irradiation. J Clin Oncol 1988;6:1576-83.
85. Mendonca MS, Rodriguez A, Alpen EL. Differential repair potentially lethal damage in exponentially growing and quiescent 9L cells. Radiat Res 1990;122:38-43.
86. Michalski JM, Graham MV, Bosh WR, Wong J, Gerber RL, Cheng A, et al. Prospective clinical evaluation of an electronic imaging device. Int J Radiat Oncol Biol Phys 1996;34:943-51.
87. Mishra RC, Parida G, Mishra TK, Mohanty S. Tumour thickness and relationship to locoregional failure in cancer of the buccal mucosa. Eur J Surg Oncol 1999;25:186-9.
88. Mubata CD, Bidmead AM, Ellingham LM, Thompson V, Dearnaley. Portal imaging protocol for radical dose-escalated radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys 1998;40:221-31.
89. Munro TR, Gilbert CW. The relation between tumor lethal dose and the radiosensivity of tumors cells. Br J Radiol 1961;34:246.
90. Obedian E, Haffty BG. Internal mammary nodal irradiation in concervatively-managed breast cancer patients: is there a benefit? Int J Radiat Oncol Biol Phys 1999;44:997-1003.
91. Ono N, Isobe I, Uki J, Kurihara H, Shimizu T, Kohno K. Recurrence of primary intracranial germinomas after complete response with radiotherapy: recurrence pattern and therapy. Neurosurgery 1994;35:615-21.
92. Oozeer R, Chauvet B, Toy BJ, Berger C, Garcia R, Felix-Faure C, et al. Définition des contours prostatiques sur coupes tomodensitométriques : études des discordances entre radiothérapeutes et entre examens. Cancer Radiother 1999;3:333-40.
93. Orr JS. Concepts, problems and the role of modifying agents in the relationship between recovery of cells survival ability and mechanisms of repair of radiation lesions. Br J Cancer 1984;49:1-6.
94. Overgaard M, Hansen PS, Overgaard J, Rose C, Andersson M, Bach F, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997;14:949-55.
95. Papillon J, Pinet A, Dargent M, Chassard JL. Radiosensibilité et radiocurabilité des cancers ano-rectaux. In: Papillon J, Pinet A, Dargent M, Chassard JI, editors. Le traitement des cancers ano-rectaux par la radiotherapie de contact. Paris: Masson et Cie éditeurs; 1960. p. 67-83.
96. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localised prostate cancer, A multi-institutional update. JAMA 1997;277:1445-51.
97. Paterson R. The treatment of malignant diseases by radium and X-rays Being a practice of radiotherapy, 2nd edition. London: Edward Arnold & Co; 1963 pp. 25-32.
98. Perez CA. Prostate. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott-Raven; 1997. p. 1586-7.
99. Perez CA, Brady LW, Roti JL. Overview. In: Perez CA, Brady LW, editors. Principles and practice of radiation oncology. Philadelphia: Lippincott-Raven; 1997. p. 42-3.
100. Perez CA, Grigsby PW, Chao SC, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998;41:307-17.
101. Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, et al. Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Cancer 1987;59:1874-81.
102. Perez CA, Stanley K, Grundy G, Hanson W, Rubin P, Kramer S, et al. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung. Cancer 1982;50:1091-9.
103. Peiffert D, Bey P, Pernot M, Guillemin F, Luporsi E, Hoffstetter S, et al. Concervative treatment by irradiation of epidermoid cancers of the anal canal: pronostic factors of tumoral control and complication. Int J Radiat Oncol Biol Phys 1997;37:313-24.
104. Pilepich MV, Krall JM, Sause WT, Johnson RJ, Russ HH, Hank GE, et al. Prognostic factors in carcinoma of the prostate-analysis of the RTOG study 75-06. Int J Radiat Oncol Biol Phys 1987;13:339-49.
105. Poupon MF, Becker M, Pauwels C, Moczar S, Korach S. Étude expérimentale des métastases des cancers. Bull Cancer 1984;71:453-63.
106. Roach M, Pickett B, Holland J, Zapotowski KA, Marsh DL, Tatera BS. The role of urethrogram during simulation for localised prostate cancer. Int J Radiat Oncol Biol Phys 1993;25:299-307.
107. Robertson JM, Ten Haken RK, Hazuka MB, Turrisi AT, Martel MK, Pu AT, et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:1079-81.
108. Rodriguez A, Alpen EL, Mendonca M, DeGuzman RJ. Recovery for potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids. Radiat Res 1988;114:515-27.
109. Roeske JC, Forman JD, Mesina CF, He T, Pelizzari CA, Fontenla E, et al. Evaluation of changes in the size and location of the prostate seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int J Radiat Oncol Biol Phys 1995;33:1321-9.
110. Sandler HM, Curran WJ, Turrisi AT. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for non-small cell lung cancer. Int J Radiat Oncol Biol Phys 1990;19:9-13.
111. Saunders M, Dische S, Barrett A, Harvey A, Gibson D, Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 1997;350:161-5.
112. Saxena V. Cancer of the tongue: a study of the regional lymph node spread. Cancer 1970;27:38-43.
113. Schewe K, Reavis J, Kun L, Cox J. Total dose, fraction size, and tumor volume in the local control of Hodgkin's disease. Int J Radiat Oncol Biol Phys 1988;15:25-8.
114. Silbergeld DL, Chicoine MR. Isolation and characterisation of human malignant glioma cells from histologically normal brain. J Neurosurg 1997;86:525-31.
115. Sobin LH, Wittekind. Introduction - The history of TNN system. In: Sobin LH, Wittekind Ch, editors. TNM Classification of malignant tumours. 5th edition. New York: John Wiley & son INC publication; 1997. p. 1-15.
116. Stanley JA, Shipley WU, Steel GG. Influence of tumor size on hypoxic fraction and therapeutic sensivity of Lewis lung tumour. Br J Cancer 1977;36:105-13.
117. Steel GG. Survival clonogenic cell-survival curve. In: Steel GG, Horwich A & A, editors. The biological basis of radiotherapy. 2nd edition. New York: Elsevier Science Publisher B,V; 1989. p. 45-62.
118. Stevens CW, Velasco JA, DiPaolo JA, Drischilo A, Notario V. Radiation response of human cervical carcinoma cells transfected with sense and antisense p53 retroviral constucts. Radiat Oncol Investing 1995;2:212-8.
119. Suit HD, Maeda M. Oxygen effect factor and tumor volume in the C3H mouse mammarycarcinoma. Am J Roentgenol 1966;96:177-82.
120. Suit HD. Basic principles of radiotherapy - Radiation biology: a basis for radiotherapy. In: Fletcher GH, editor. Textbook of radiotherapy. 2nd edition. Philadelphia: Lea & Febiger; 1973. p. 121-51.
121. Suit HD, Mankin HJ, Wood WC, Proppe KH. Preoperative, intraoperative, and postoperative radiotherapy in the treatment of primary soft tissue sarcoma. Cancer 1985;55:2659-67.
122. Tannock IF. The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer 1968;22:258-73.
123. Tannock IF, Kopelyan I. Influence of glucose concentration on growth and formation of necrosis in spheroids derived from a human bladder cancer cell line. Cancer Res 1986;46:3105-10.
124. Teisher BA, Dupuis NP, Holden SA, Schawrtz GN, Lester S, Frei E. Definition and manipulation of tumor oxygenation. Radiat Oncol Investig 1994;2:66-76.
125. Teisher BA, Holden SA, Ara G, Dupuis NP, Liu F, Yan J, et al. Influence of an anti-angiogenic treatment on 9L gliosarcoma oxygenation and response to cytotoxic therapy. Int J Cancer 1995;61:732-7.
126. Thomas F, Arriagada R, Mouriesse H, Sillet-Bach I, Kunkler I, Fontaine F, et al. Radical radiotherapy alone in non-operable breast cancer: the major impact of tumor size and histological grade on prognosis. Radiother Oncol 1988;13:267-76.
127. Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implication for radiotherapy. Br J Radiol 1955;9:539-49.
128. Tubiana M, Dutreix A, Wanbersie A. Radiobiologie. Paris: Herman éditeurs; 1986 pp. 141-146.
129. Tubiana M, Dutreix A, Wanbersie A. Radiobiologie. Paris: Herman éditeurs; 1986 p. 159.
130. Tubiana M, Dutreix A, Wanbersie A. Radiobiologie. Paris: Herman éd.; 1986 p. 161-162.
131. Tubiana M, Kocielny S. Histoire naturelle des cancers humains et facteurs pronostiques. L'exemple du cancer du sein. Bull Cancer 1987;74:43-57.
132. Turrisi AT. It's about time, or is it about volume, fractionation, or technique?. Int J Radiat Oncol Biol Phys 1996;36:753-5.
133. Willner J, Baier K, Pfreundner L, Flentje M. Tumor volume and local control in primary radiotherapy of nasopharyngeal carcinoma. Acta Oncol 1999;38:1025-30.
134. Withers HR. The effect of oxygen and anaesthesia on radiosensivity in vivo of epithelial cells of mouse skin. Br J Radiol 1967;40:343-55.
135. Withers HR, Peters LJ. Basic principles of radiotherapy - Biologic aspect of radiation therapy. In: Fletcher GH, editor. Textbook of radiotherapy. 3rd edition. Philadelphia: Lea & Febiger; 1980. p. 119-21.
136. Withers HR, Peters LJ. Basic principles of radiotherapy - Basic clinical parameters. In: Fletcher GH, editor. Textbook of radiotherapy. 3rd edition. Philadelphia: Lea & Febiger; 1980. p. 180-218.
137. Yaes RJ. Tumor heterogeneity, tumor size and radioresistance. Int J Radiat Oncol Biol Phys 1989;17:993-1005.
138. Yaes RJ. The biological effect of inhomogenous dose distribution in fractionated radiotherapy. Int J Radiat Oncol Biol Phys 1990;19:203-7.
139. Yah D, Ziaja E, Jaffray D, Wong J, Brabbins D, Vicini F, et al. The use of adaptive radiation therapyto reduce set-up error: a prospective clinical study. Int J Radiat Oncol Biol Phys 1998;41:715-20.
140. Young SD, Marshall RS, Hill RP. Hypoxia induce DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci 1988;85:9533-7.
141. Zelefsky MJ, Cream D, Mageras GS, Lyass O, Happersett L, Ling CC, et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol 1999;50:225-34.